CD40 promotes the development of early diabetic retinopathy in mice

Diabetologia

Volumn 57, Issue 10, 2014, Pages 2222-2231

  Portillo, Jose Andres C ^a   Greene, Jennifer A ^a   Okenka, Genevieve ^a   Miao, Yanling ^a   Sheibani, Nader ^b   Kern, Timothy S ^a,c   Subauste, Carlos S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

CD40; Diabetic retinopathy; Endothelial cells; Inflammation; M ller cells; Pathogenesis; Retina

Indexed keywords

CD40 ANTIGEN; CONCANAVALIN A; FLUORESCEIN ISOTHIOCYANATE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; ISOPHANE INSULIN; MESSENGER RNA; NITRIC OXIDE; STREPTOZOCIN; CASC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL REACTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GRIESS REACTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUKOSTASIS; LIGATION; MALE; MICROGLIA; MOUSE; MUELLER CELL; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RETINA; RETINA BLOOD VESSEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; MACROGLIA; METABOLISM;

ANIMALS; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; EPENDYMOGLIAL CELLS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84939815915     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3321-x     Document Type: Article

References (45)

1. Mizutani M, Kern TS, Lorenzi M (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97:2883–2890
2. Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30:343–358
3. McLeod DS, Lefer DJ, Merges C, Lutty GA (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147:642–653
4. Joussen AM, Poulaki V, Le ML et al (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450–1452
5. Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K (2001) Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 132:551–556
6. Du Y, Smith MA, Miller CM, Kern TS (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771–779
7. Zheng L, Du Y, Miller C et al (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50:1987–1996
8. Leal EC, Manivannan A, Hosoya K-I et al (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48:5257–5265
9. van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leuk Biol 67:2–17
10. Peters AL, Stunz LL, Bishop GA (2009) CD40 and autoimmunity: the dark side of a great activator. Semin Immunol 21:293–300
11. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394:200–203
12. Lutgens E, Gorelik L, Daemen MJAP et al (1999) Requirement for CD154 in the progression of atherosclerosis. Nat Med 5:1313–1316
13. Portillo J-AC, Okenka G, Kern TS, Subauste CS (2009) Identification of primary retinal cells and ex vivo identification of pro-inflammatory molecules in retinal cells using flow cytometry. Mol Vis 15:1383–1389
14. Yngen M, Ostenson C-G, Hu HM, Li N, Hjemdahl P, Wallen NH (2004) Enhanced P-selectin expression and increased soluble CD40 ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 47:537–540
15. Portillo J-AC, van Grol J, Zheng L et al (2008) CD40 mediates retinal inflammation and neuro-vascular degeneration. J Immunol 181:8719–8726
16. Schroder K, Vecchione C, Jung O et al (2006) Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free Radic Biol Med 41:1353–1360
17. Zheng L, Szabo C, Kern TS (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor kappaB. Diabetes 53:2960–2967
18. Capetandes A, Gerritsen ME (1990) Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest Ophthalmol Vis Sci 31:1738–1744
19. Puro DG (1994) Calcium channels of human retinal glial cells. In: Narahashi T (ed) Ion channels of excitable cells. Methods in neurosciences, vol. 19. Academic, Orlando, pp 68–81
20. Bajorath J, Seyama K, Nonoyama S, Ochs HD, Aruffo A (1996) Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome. Protein Sci 5:531–534
21. Scheef E, Wang S, Sorenson CM, Sheibani N (2005) Isolation and characterization of murine retinal astrocytes. Mol Vis 11:613–624
22. Gubitosi-Klug RA, Talahalli R, Du Y, Nadler JL, Kern TS (2008) 5-Lipoxygenase but not 12/15-lipoxygenase contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 57:1387–1393
23. Ohh M, Smith CA, Carpenito C, Takei F (1994) Regulation of intracellular adhesion molecule-1 gene expression involves multiple mRNA stabilization mechanisms: effects of inteferon-γ and phorbol myristate acetate. Blood 84:2632–2639
24. Nagai N, Izumi-Nagai K, Oike Y et al (2007) Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-κB pathway. Invest Ophthalmol Vis Sci 48:4342–4350
25. Bruemmer D, Riggers U, Holzmeister J et al (2001) Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am J Cardiol 87:21–27
26. Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 92:4342–4346
27. Subauste CS, Wessendarp M (2000) Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-γ. J Immunol 165:1498–1505
28. El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, Caldwell RB (2003) Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162:1995–2004
29. Kowluru RA, Kanwar M, Kennedy A (2007) Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res 2007:21976
30. Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57:889–898
31. Kowluru RA (2003) Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52:818–823
32. Kanwar M, Chan PS, Kern TS, Kowluru RA (2007) Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 48:3805–3811
33. Jana M, Liu X, Koka S, Ghosh S, Petro TM, Pahan K (2001) Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem 276:44527–44533
34. Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S (2002) CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106:981–986
35. Lieth E, Barber AJ, Xu B et al (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 47:815–820
36. Gerbardinger C, Biarnes Costa M, Coulombe MC, Toth I, Hoehn T, Grosu P (2005) Expression of acute-phase response proteins in retinal Müller cells in diabetes. Invest Ophthalmol Vis Sci 46:349–357
37. Meleth AD, Agron E, Cha C-C et al (2005) Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46:4295–4301
38. Rungger-Brandle E, Dosso AA, Leuenberger PM (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971–1980
39. Henn V, Slupsky JR, Grafe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591–594
40. Boeri D, Maiello M, Lorenzi M (2001) Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 50:1432–1439
41. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98:1047–1053
42. Varo N, Vincent D, Libby P et al (2003) Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients. A novel target of thiazolidinediones. Circulation 107:2644–2649
43. Cipollone F, Chiarelli F, Davi G et al (2005) Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 48:1216–1224
44. Portillo J-AC, Muniz-Feliciano L, Subauste MC, Heinzel FP, Subauste CS (2012) CD40 and TNF-α synergize to induce nitric oxide synthase in macrophages. Immunology 135:140–150
45. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D (1995) Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917–4925